Loomis Sayles & CO L P Vertex Pharmaceuticals Inc Transaction History

Loomis Sayles & CO L P

$79.2 Billion
Q4 2024

A detailed history of Loomis Sayles & CO L P transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Loomis Sayles & CO L P holds 3,772,789 shares of VRTX stock, worth $1.84 Billion. This represents 1.92% of its overall portfolio holdings.

Number of Shares

3,772,789

Previous 3,068,214 22.96%

Holding current value

$1.84 Billion

Previous $1.43 Billion 6.47%

% of portfolio

1.92%

Previous 1.87%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$396.64 - $516.74 $279 Million - $364 Million	704,575 Added 22.96%	3,772,789 $1.52 Billion
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $34 Million - $37.4 Million	-73,957 Reduced 2.35%	3,068,214 $1.43 Billion
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $12.5 Million - $15.4 Million	31,743 Added 1.02%	3,142,171 $1.47 Billion
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $9.96 Million - $10.9 Million	-24,424 Reduced 0.78%	3,110,428 $1.3 Billion
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $9.82 Million - $11.8 Million	-28,616 Reduced 0.9%	3,134,852 $1.28 Billion
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $37.8 Million - $40.5 Million	-111,842 Reduced 3.41%	3,163,468 $1.1 Billion
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $30.3 Million - $33.9 Million	-96,336 Reduced 2.86%	3,275,310 $1.15 Billion
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $110 Million - $125 Million	-387,524 Reduced 10.31%	3,371,646 $1.06 Billion
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $114 Million - $128 Million	-399,220 Reduced 9.6%	3,759,170 $1.09 Billion
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $82 Million - $91.5 Million	-299,346 Reduced 6.72%	4,158,390 $1.2 Billion
Q2 2022 Aug 05, 2022	SELL	$234.96 - $292.55 $454 Million - $565 Million	-1,931,287 Reduced 30.23%	4,457,736 $1.26 Billion
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $54.5 Million - $64.3 Million	-246,230 Reduced 3.71%	6,389,023 $1.67 Billion
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $65.6 Million - $82.8 Million	-370,739 Reduced 5.29%	6,635,253 $1.46 Billion
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $899 Million - $1.01 Billion	4,955,119 Added 241.61%	7,005,992 $1.27 Billion
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $384 Million - $453 Million	2,049,877 Added 205810.94%	2,050,873 $414 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $167,686 - $195,461	810 Added 435.48%	996 $214,000
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $91,084 - $121,479	-440 Reduced 70.29%	186 $44,000
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $40,648 - $48,192	159 Added 34.05%	626 $170,000
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $9,244 - $12,127	-41 Reduced 8.07%	467 $136,000
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $5,194 - $6,443	26 Added 5.39%	508 $121,000
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $80,354 - $107,924	482 New	482 $106,000

Others Institutions Holding VRTX

# of Institutions

1,761

Shares Held

228M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $125B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account

Loomis Sayles & CO L P Vertex Pharmaceuticals Inc Transaction History